Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertions

Affiliations

• ¹ Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
• ² Centre for Cancer Research, University of Melbourne, Parkville, VIC, Australia.
• ³ Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
• ⁴ Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
• ⁵ Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
• ⁶ The Beijer Laboratory, Uppsala, Sweden.
• ⁷ Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
• ⁸ Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
• ⁹ Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
• ¹⁰ Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
• ¹¹ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
• ¹² Murdoch Children's Research Institute, Parkville, VIC, Australia.
• ¹³ Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.
• ¹⁴ Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.
• ¹⁵ Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia.
• ¹⁶ Munich Leukemia Laboratory, Munich, Germany.
• ¹⁷ Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
• ¹⁸ Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN.
• ¹⁹ Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.